Development of An Oral Treatment with the PPAR-γ-Acting Cannabinoid VCE-003.2 Against the Inflammation-Driven Neuronal Deterioration in Experimental Parkinson’s Disease
出版年份 2019 全文链接
标题
Development of An Oral Treatment with the PPAR-γ-Acting Cannabinoid VCE-003.2 Against the Inflammation-Driven Neuronal Deterioration in Experimental Parkinson’s Disease
作者
关键词
-
出版物
MOLECULES
Volume 24, Issue 15, Pages 2702
出版商
MDPI AG
发表日期
2019-07-25
DOI
10.3390/molecules24152702
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson’s disease: possible involvement of different binding sites at the PPARγ receptor
- (2018) Concepción García et al. Journal of Neuroinflammation
- Neuroinflammation in Synucleinopathies
- (2016) Somin Lim et al. BRAIN PATHOLOGY
- Targeting the cannabinoid CB 2 receptor to attenuate the progression of motor deficits in LRRK2-transgenic mice
- (2016) Cristina Palomo-Garo et al. PHARMACOLOGICAL RESEARCH
- Potential of the cannabinoid CB2 receptor as a pharmacological target against inflammation in Parkinson's disease
- (2016) Yolanda Gómez-Gálvez et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington’s disease
- (2016) Javier Díaz-Alonso et al. Scientific Reports
- Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses
- (2015) Valerio Chiurchiù et al. Journal of Neuroimmune Pharmacology
- Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications
- (2015) Javier Fernández-Ruiz et al. Neurotherapeutics
- PPARγand the Innate Immune System Mediate the Resolution of Inflammation
- (2015) Amanda Croasdell et al. PPAR Research
- Neuroprotective Properties of Peroxisome Proliferator-Activated Receptor Alpha (PPARα) and its Lipid Ligands
- (2014) Marco Fidaleo et al. CURRENT MEDICINAL CHEMISTRY
- Thiazolidinediones under preclinical and early clinical development for the treatment of Parkinson’s disease
- (2014) Anna R Carta et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Dysregulation of lysosomal morphology by pathogenic LRRK2 is corrected by TPC2 inhibition
- (2014) L. N. Hockey et al. JOURNAL OF CELL SCIENCE
- A Cannabigerol Derivative Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis
- (2014) Francisco J. Carrillo-Salinas et al. PLoS One
- An alternate binding site for PPARγ ligands
- (2014) Travis S. Hughes et al. Nature Communications
- Autophagic Impairment Contributes to Systemic Inflammation-Induced Dopaminergic Neuron Loss in the Midbrain
- (2013) Hui-Fen Zheng et al. PLoS One
- Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
- (2013) Sheila M. Fleming et al. Jove-Journal of Visualized Experiments
- Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?
- (2012) Javier Fernández-Ruiz et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis
- (2012) Aitor G. Granja et al. Journal of Neuroimmune Pharmacology
- Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ9-THCV in animal models of Parkinson's disease
- (2011) C García et al. BRITISH JOURNAL OF PHARMACOLOGY
- From Surface to Nuclear Receptors: The Endocannabinoid Family Extends its Assets
- (2010) M. Pistis et al. CURRENT MEDICINAL CHEMISTRY
- Synaptic dysfunction in genetic models of Parkinson's disease: A role for autophagy?
- (2010) Edward D. Plowey et al. NEUROBIOLOGY OF DISEASE
- WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease
- (2009) David A. Price et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Cannabinoid activation of peroxisome proliferator-activated receptors: Potential for modulation of inflammatory disease
- (2009) S.E. O'Sullivan et al. IMMUNOBIOLOGY
- Intrastriatal lipopolysaccharide injection induces parkinsonism in C57/B6 mice
- (2009) Randy L. Hunter et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Neuroinflammation in Parkinson's disease: a target for neuroprotection?
- (2009) Etienne C Hirsch et al. LANCET NEUROLOGY
- Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention
- (2009) Malú G. Tansey et al. NEUROBIOLOGY OF DISEASE
- Formyl-methionyl-leucyl-phenylalanine–Induced Dopaminergic Neurotoxicity via Microglial Activation: A Mediator between Peripheral Infection and Neurodegeneration?
- (2008) Xi Gao et al. ENVIRONMENTAL HEALTH PERSPECTIVES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search